|

OAC will be discontinued for the duration of the trial Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Odense University Hospital1

Indications

  • Anticoagulant Adverse Reaction1
  • Left Atrial Appendage Absent1
  • Heart Disease1
  • Atrial Fibrillation1

Other1 trial

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.